ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

15,468Medicare Part D Prescriptions Filled, Including Refills

Rank: 102 out of 680

$1.18M Total Retail Price of All Prescriptions

Rank: 50 out of 680

466 Patients Receiving at Least One Drug in Part D
84%Patients 65 Years and Older
56% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Louisiana
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 466 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

16% of this provider’s 466 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

2% of this provider’s 13,525 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

37% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$76 was the average price of a prescription from this provider, compared to $59 among peers.

Prescriptions per Patient

33 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
LEVOTHYROXINE SODIUM 442 408 1 2
AMLODIPINE BESYLATE 440 398 2 1
POTASSIUM CHLORIDE 438 406 3 14
HYDROCODONE-ACETAMINOPHEN 435 277 S3 4 4
PRAVASTATIN SODIUM 426 379 5 10
NAMENDA 425 393 6 35
FUROSEMIDE 412 392 7 6
METOPROLOL SUCCINATE 302 264 8 13
BENAZEPRIL HCL 272 271 9 40
OMEPRAZOLE 258 227 10 7
SIMVASTATIN 236 217 11 3
BYSTOLIC 230 220 12 79
ATORVASTATIN CALCIUM 218 182 13 11
METFORMIN HCL 211 179 14 8
EXELON 203 203 15 112
WARFARIN SODIUM 191 163 16 20
AMLODIPINE BESYLATE-BENAZEPRIL 182 170 17 43
FENOFIBRATE 138 115 18 66
TRAMADOL HCL 135 119 19 18
ZETIA 135 122 19 87
NEXIUM 126 66 21 16
DIGOXIN 125 113 22 58
CRESTOR 115 97 23 25
HYDROCHLOROTHIAZIDE 114 111 24 9
GLIMEPIRIDE 114 111 24 29
ESCITALOPRAM OXALATE 114 100 24 45
LISINOPRIL 110 100 27 5
LOSARTAN POTASSIUM 109 101 28 21
TAMSULOSIN HCL 109 101 28 34
DOXAZOSIN MESYLATE 108 108 30 73
GABAPENTIN 106 98 31 15
DIOVAN 105 89 32 31
SPIRIVA 104 85 33 70
DONEPEZIL HCL 104 100 33 27
SERTRALINE HCL 101 78 35 28
ZOLPIDEM TARTRATE 101 82 35 17
PANTOPRAZOLE SODIUM 99 72 37 30
METFORMIN HCL ER 98 96 38 54
FLUTICASONE PROPIONATE 97 92 39 41
DIOVAN HCT 96 96 40 55
QUETIAPINE FUMARATE 95 72 41 64
LANTUS 95 89 41 49
METOPROLOL TARTRATE 95 84 41 12
CITALOPRAM HBR 94 85 44 22
CLOPIDOGREL 91 81 45 26
PRISTIQ ER 87 64 46 241
TEKTURNA 85 83 47 331
CARVEDILOL 85 72 47 23
SPIRONOLACTONE 85 80 47 82
RAMIPRIL 83 82 50 69
ATENOLOL 81 76 51 19
ADVAIR DISKUS 80 79 52 53
MUPIROCIN 79 68 53 130
SANTYL 77 77 54 170
AMITRIPTYLINE HCL 73 63 R 55 47
WELCHOL 71 71 56 223
JANUVIA 70 60 57 60
PREDNISONE 69 68 58 50
PREMARIN 67 66 R 59 105
BISOPROLOL-HYDROCHLOROTHIAZIDE 63 50 60 156
LIPITOR 62 47 61 68
LACTULOSE 62 62 61 92
METOLAZONE 62 62 61 201
CIPROFLOXACIN HCL 62 53 61 57
ROPINIROLE HCL 60 50 65 99
LYRICA 58 52 66 77
ALLOPURINOL 57 47 67 33
LEXAPRO 56 53 68 128
PLAVIX 55 52 69 39
TRIAMTERENE-HCTZ 53 53 70 52
MELOXICAM 51 30 71 24
LOSARTAN-HYDROCHLOROTHIAZIDE 51 51 71 51
FLUOXETINE HCL 51 29 71 74
RISPERIDONE 51 47 71 80
MIRTAZAPINE 50 50 75 78
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 8, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.